Avelumab Plus Autologous Dendritic Cell Vaccine in Pre-treated Metastatic Colorectal Cancer Patients

ABSTRACT: Single arm Phase I/II multicentric open labeled, with translational sub-study, of avelumab plus autologous dendritic cell vaccine in pre-treated mismatch repair-proficient (MSS) metastatic colorectal cancer patients..

DISEASE(S): Colorectal Carcinoma,Colorectal Neoplasms,Mss Colorectal Adenocarcinoma,Colorectal Cancer Metastatic,Adenocarcinoma Colorrectal Mss

PROVIDER: 2244333 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR